Join experts as they provide information and answer questions about myeloproliferative neoplasms (MPN) to help patients and caregivers compare, discuss, and select treatment options with their doctor. See list below for topics discussed. Please note that this is a not an accredited activity.

Topics Discussed:
00:00 Welcome and Introductions
02:24 Myeloproliferative Neoplasms (MPN) Disease Overview and Diagnosis
07:50 Team Approach to Care
10:18 What to Expect After MPN Diagnosis
14:50 PV and ET: Initial Treatment and Watchful Waiting
24:03 General Considerations of Managing MPN Patients
25:13 Symptom Assessment
26:06 Outlook of PV and ET
27:33 Symptom Management and Healthy Living
32:02 Myelofibrosis
41:31 When to Consult with an MPN Specialist
45:45 Financial Assistance
48:28 How to Be Your Best Advocate
53:29 Question & Answer Session
1:07:48 Closing Remarks

Question & Answer Session
53:38 Should iron levels be part of testing along with complete blood counts (CBC)?
55:12 Since the FDA approved Ropeginterferon for PV treatment, would it be considered a first line therapy?
56:08 Should Ropeginterferon be used for young, lower risk patients?
58:36 Is there a risk of over hydration having a result on your CBC?
59:48 Is there more specific testing for prognosis?
1:02:10 Long term risks for being on hydroxyurea?
1:04:29 Does the treatment of a younger adult different than an older adult?
1:05:59 What are the next steps for a person diagnosed with triple negative ET?


The Patient Webinar: Myeloproliferative Neoplasms (MPN) occurred in April 2022. This informational program was created in conjunction with the recently updated NCCN Guidelines for Patients® for Myeloproliferative Neoplasms. https://www.nccn.org/patientresources...)

The NCCN Guidelines for Patients (http://nccn.org/patientguidelines) are available to read and download for free online and via the NCCN Patient Guides for Cancer mobile app. Printed editions can be ordered from Amazon.com for a small fee.

NCCN Guidelines for Patients DO NOT replace the expertise and clinical judgment of the clinician.

Supporters:
This webinar is supported through the NCCN Foundation and by contributions from our corporate supporters: AbbVie; Bristol Myers Squibb; and Incyte Corporation.
________________________________________________________________
About NCCN Foundation®:
NCCN FOUNDATION® is a 501(c)3 organization founded by the National Comprehensive Cancer Network® (NCCN®)—a notforprofit alliance of leading cancer centers devoted to patient care, research, and education—to empower people living with cancer and advance oncology innovation. For more information or to make a donation, visit http://www.nccn.org/patients/foundation
________________________________________________________________
About NCCN:
The National Comprehensive Cancer Network® (NCCN®) is a notforprofit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, equitable, and accessible cancer care so all patients can live better lives. Visit https://www.nccn.org/ for more information.

Subscribe to our channel for the latest in cancer care: https://www.youtube.com/c/NCCNvideo?s...

Connect with us!
Twitter:   / nccn  
LinkedIn:   / nccn  
Facebook:   / nccnorg  
Instagram:   / nccnorg